Back to Funding Opportunities

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) - PAR-25-063

Funder
National Institutes of Health
LOI Required
No
Application Deadline
Maximum Project Duration
5 years
Research Focus Areas
Molecular and Cellular
Neurobiology/Neuroscience
Pharmacotherapy
Research Methods
Quantitative Research Methods
Description
Through this Notice of Funding Opportunity, (NOFO), NIMH wishes to stimulate research in the discovery and development of novel screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a �hit� is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. Stages of discovery research covered by this NOFO include 1) assay development; 2) primary screen implementation to identify initial screening hits (high throughput target-focused screens, or moderate throughput screens); and 3) hit validation using a series of assays and initial medicinal chemistry inspection to prioritize the hit set.